The role of placebo response in the efficacy outcome assessment in viloxazine extended-release pivotal trials in pediatric subjects with ADHD

CONCLUSION: This analysis indicated that a higher placebo response in Study 812P304 confounded the assessment of treatment effect. Application of the band-pass methodology confirmed the positive results of the three prior studies and the signal detection confounder in the fourth study.

via https://pubmed.ncbi.nlm.nih.gov/35588245/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20220607011004&v=2.17.6